Can painting human cells with exogenous maltoporin enable efficient therapeutic gene transfer by bacteriophage lambda vectors?
Many gene therapy strategies require transfer of high-molecular weight DNA into human cells. To enable clinical trials, these vectors need to be produced on a large scale and at low cost. The production of effective high-capacity vectors like HSV-amplicons and helper-dependent adenoviral vectors is...
Guardado en:
Autor principal: | Tolmachov,Oleg |
---|---|
Lenguaje: | English |
Publicado: |
Pontificia Universidad Católica de Valparaíso
2009
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582009000400012 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A CI-independent form of replicative inhibition: turn off of early replication of bacteriophage lambda.
por: Sidney Hayes, et al.
Publicado: (2012) -
Molecular Modeling the Proteins from the <i>exo-xis</i> Region of Lambda and Shigatoxigenic Bacteriophages
por: Logan W. Donaldson
Publicado: (2021) -
Nano-vectors for efficient liver specific gene transfer
por: Atul Pathak, et al.
Publicado: (2008) -
The Bacteriophage lambdaDNA packaging enzyme: Identification of four structural domains of the gpNu1 subunit using limited proteolysis
por: ARAYA,PAMELA, et al.
Publicado: (2001) -
Novel “Superspreader” Bacteriophages Promote Horizontal Gene Transfer by Transformation
por: Eric C. Keen, et al.
Publicado: (2017)